Status:
COMPLETED
Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This protocol will evaluate a new non-invasive infrared imaging system as an adjunctive tool for breast cancer detection that has been approved by the FDA. The technology and device have been develope...
Detailed Description
The research study will evaluate the sensitivity and specificity of a new non-invasive digital infrared imaging system as an adjunctive test for breast cancer detection (as approved by the FDA under 2...
Eligibility Criteria
Inclusion
- Mammographic Breast Abnormality requiring a follow up biopsy
- Sonographic Breast Abnormality requiring a follow up biopsy
- Clinical Breast Abnormality requiring a follow up biopsy
Exclusion
- Active Breast Inflammation
- Previous history of breast augmentation
- Bra size greater than DD
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00195026
Start Date
March 1 2005
Last Update
March 18 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Breast Center
New York, New York, United States, 10021